ArticleNature communications2024

A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models.

Henri Leinonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.